Dragan B Djordjević1,2, Ivan S Tasić1,2, Svetlana I Kostić2, Bojana N Stamenković1,3, Aleksandar D Djordjević4, Dragan B Lović5. 1. Medical Faculty, Department of Internal Medicine, University of Niš, Niš, Serbia. 2. Department of Cardiology, Institute for Treatment and Rehabilitation Niška Banja, Niš, Serbia. 3. Department of Rheumatology, Institute for Treatment and Rehabilitation Niška Banja, Niš, Serbia. 4. Medical Faculty, University of Niš, Niš, Serbia. 5. Department of Cardiology, Clinic for Internal Diseases Intermedica, Niš, Serbia; and Veterans Affairs Medical Center, Washington, District of Columbia.
Abstract
BACKGROUND: Persistent and adequate treatment of patients with arterial hypertension leads to more favorable disease outcome. HYPOTHESIS: Aside for the present left ventricular hypertrophy (LVH), there are other non-invasive parameters which can represent additional predictors of unfavorable prognosis in patients with essential arterial hypertension during the 10-year follow-up. METHODS: A hypertensive group with LVH (124 patients; age 57.0 ± 8.0; 84 males and 40 females) was included in the study and examined noninvasively. Patients used regular medication therapy during the follow-up period. RESULTS: During the 10-year follow-up period, unfavorable outcome was recorded for 40 (32.3%) patients. Patients with unfavorable outcome had higher baseline values of left ventricular mass index (178.9 ± 29.5 g/m2 vs 165.5 ± 29.5 g/m2 ; P < 0.05) and QTc dispersion (64.1 ± 24.7 ms vs 54.8 ± 19.4 ms; P < 0.05). Frequency of positive Cornell product was higher in the group of patients with unfavorable outcome (35% vs 22.2%; P < 0.01). Positive Lyon-Sokolow score did not show statistical significance (25% vs 11.9%; P = 0.06). Cornell product (β = 0.234; P < 0.01) and QTc dispersion >65 ms (β = 0.184; P < 0.05) had prognostic significance in LVH (multiple regression analysis: R = 0.314, R = 0.099, adjusted R = 0.084, standard error of the estimate = 0.449, P < 0.05). CONCLUSIONS: Patients with a positive Cornell product and larger QTc dispersion had more unfavorable 10-year outcomes compared with other patients with LVH.
BACKGROUND: Persistent and adequate treatment of patients with arterial hypertension leads to more favorable disease outcome. HYPOTHESIS: Aside for the present left ventricular hypertrophy (LVH), there are other non-invasive parameters which can represent additional predictors of unfavorable prognosis in patients with essential arterial hypertension during the 10-year follow-up. METHODS: A hypertensive group with LVH (124 patients; age 57.0 ± 8.0; 84 males and 40 females) was included in the study and examined noninvasively. Patients used regular medication therapy during the follow-up period. RESULTS: During the 10-year follow-up period, unfavorable outcome was recorded for 40 (32.3%) patients. Patients with unfavorable outcome had higher baseline values of left ventricular mass index (178.9 ± 29.5 g/m2 vs 165.5 ± 29.5 g/m2 ; P < 0.05) and QTc dispersion (64.1 ± 24.7 ms vs 54.8 ± 19.4 ms; P < 0.05). Frequency of positive Cornell product was higher in the group of patients with unfavorable outcome (35% vs 22.2%; P < 0.01). Positive Lyon-Sokolow score did not show statistical significance (25% vs 11.9%; P = 0.06). Cornell product (β = 0.234; P < 0.01) and QTc dispersion >65 ms (β = 0.184; P < 0.05) had prognostic significance in LVH (multiple regression analysis: R = 0.314, R = 0.099, adjusted R = 0.084, standard error of the estimate = 0.449, P < 0.05). CONCLUSIONS:Patients with a positive Cornell product and larger QTc dispersion had more unfavorable 10-year outcomes compared with other patients with LVH.
Authors: Surya M Artham; Carl J Lavie; Richard V Milani; Dharmendrakumar A Patel; Anil Verma; Hector O Ventura Journal: Prog Cardiovasc Dis Date: 2009 Sep-Oct Impact factor: 8.194
Authors: Ruth O Teh; Ngaire M Kerse; Elizabeth M Robinson; Gillian A Whalley; Martin J Connolly; Robert N Doughty Journal: Heart Lung Circ Date: 2014-07-08 Impact factor: 2.975
Authors: P Dilaveris; E Gialafos; J Poloniecki; K Hnatkova; D Richter; G Andrikopoulos; E Lazaki; J Gialafos; M Malik Journal: Clin Cardiol Date: 2000-08 Impact factor: 2.882
Authors: Alberto Bouzas-Mosquera; Francisco J Broullón; Nemesio Álvarez-García; Jesús Peteiro; Víctor X Mosquera; Alfonso Castro-Beiras Journal: PLoS One Date: 2012-09-26 Impact factor: 3.240
Authors: Dragan B Djordjević; Ivan S Tasić; Svetlana I Kostić; Bojana N Stamenković; Aleksandar D Djordjević; Dragan B Lović Journal: Clin Cardiol Date: 2017-12-16 Impact factor: 2.882
Authors: Dragan B Djordjevic; Ivan S Tasic; Svetlana T Kostic; Bojana N Stamenkovic; Milan B Lovic; Nikola D Djordjevic; Goran P Koracevic; Dragan B Lovic Journal: Clin Cardiol Date: 2020-06-03 Impact factor: 2.882